SCHEMBL650364

SCHEMBL650364

CCCC(C)C([O])C=S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4256820 0.70
SCHEMBL276772 0.70 METAP1 (0.31)
SCHEMBL285270 0.70
SCHEMBL2330688 0.69
SCHEMBL22027595 0.67 TSHR (0.44)
SCHEMBL598768 0.67 TSHR (0.44)
SCHEMBL277332 0.67
SCHEMBL6575593 0.67 METAP1 (0.47)
SCHEMBL4393307 0.65
SCHEMBL17581967 0.65 METAP1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2988753-A1 METHODS TO MODULATE RAC1 IMPORT AND TO TREAT PULMONARY FIBROSIS University of Iowa Research Foundation (US) 2016-03-02 EP claimed
WO-2014176546-A1 METHODS TO MODULATE RAC1 IMPORT AND TO TREAT PULMONARY FIBROSIS UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2014-10-30 WO claimed
EP-1793832-B1 GERANYLGERANYL PYROPHOSPHATE SYNTHASE INHIBITORS UNIV IOWA RES (US) 2014-07-23 EP claimed
US-7268124-B2 Geranylgeranyl pyrophosphate synthase inhibitors UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2007-09-11 US claimed
EP-1793832-A2 GERANYLGERANYL PYROPHOSPHATE SYNTHASE INHIBITORS University of Iowa Research (US) 2007-06-13 EP claimed
US-20060052347-A1 Geranylgeranyl pyrophosphate synthase inhibitors UNIVERSITY OF IOWA RESEARCH FOUNDATION 2006-03-09 US claimed
WO-2006026380-A2 GERANYLGERANYL PYROPHOSPHATE SYNTHASE INHIBITORS UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2006-03-09 WO claimed
EP-1485396-A2 NUCLEOSIDE 5'-MONOPHOSPHATE MIMICS AND THEIR PRODRUGS Biota, Inc. (US) 2004-12-15 EP claimed
US-20040023901-A1 Nucleoside 5'-monophosphate mimics and their prodrugs BIOTA HOLDINGS LIMITED (AU) 2004-02-05 US claimed
WO-2003073989-A2 NUCLEOSIDE 5'-MONOPHOSPHATE MIMICS AND THEIR PRODRUGS BIOTA, INC. (US) 2003-09-12 WO claimed
US-9416149-B2 Methods to modulate Rac1 import and to treat pulmonary fibrosis UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2016-08-16 US disclosed
EP-2988753-A1 METHODS TO MODULATE RAC1 IMPORT AND TO TREAT PULMONARY FIBROSIS University of Iowa Research Foundation (US) 2016-03-02 EP disclosed
US-20150005261-A1 METHODS TO MODULATE RAC1 IMPORT AND TO TREAT PULMONARY FIBROSIS UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2015-01-01 US disclosed
WO-2014176546-A1 METHODS TO MODULATE RAC1 IMPORT AND TO TREAT PULMONARY FIBROSIS UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) 2014-10-30 WO disclosed
US-8802840-B2 Bicyclic nucleosides and nucleotides as therapeutic agents BIOTA SCIENTIFIC MANAGEMENT PTY LTD. (AU) 2014-08-12 US disclosed
US-20060052347-A1 Geranylgeranyl pyrophosphate synthase inhibitors UNIVERSITY OF IOWA RESEARCH FOUNDATION 2006-03-09 US disclosed
WO-2005021568-A2 NOVEL TRICYCLIC NUCLEOSIDES OR NUCLEOTIDES AS THERAPEUTIC AGENTS BIOTA, INC. (AU) 2005-03-10 WO disclosed
EP-1485396-A2 NUCLEOSIDE 5'-MONOPHOSPHATE MIMICS AND THEIR PRODRUGS Biota, Inc. (US) 2004-12-15 EP disclosed
US-20040023901-A1 Nucleoside 5'-monophosphate mimics and their prodrugs BIOTA HOLDINGS LIMITED (AU) 2004-02-05 US disclosed
WO-2003073989-A2 NUCLEOSIDE 5'-MONOPHOSPHATE MIMICS AND THEIR PRODRUGS BIOTA, INC. (US) 2003-09-12 WO disclosed